ブラジルの抗レトロウイルス薬へのアクセス
1Fogarty International AIDS Training Programme, School of Public Health, University of California, Berkeley, CA, USA. jgalvao@uclink.berkeley.edu
Lancet (London, England)
|December 14, 2002
まとめ
ブラジルは,無料のHIV/AIDS治療を提供しているが,医薬品の調達と流通の課題に直面している. この普遍的なアクセス政策から学んだ教訓は,世界的な健康戦略の洞察を提供します.
科学分野:
- 公衆衛生は公衆衛生である.
- 保健政策 保健政策 保健政策
- 医薬品マネジメント
背景:
- ブラジルの保健省は,1996年以来,HIV/エイズに感染している人々に対して,無料で普遍的な抗レトロウイルス治療 (ARV) を提供している.
- この政策の実施は,政治的,財政的,物流的な大きな障害に直面しています.
研究 の 目的:
- ブラジルのARV治療政策の歴史的文脈と進化を調査する.
- ブラジルのARVの薬物配布の物流と政府調達戦略を分析する.
主な方法:
- 歴史的政策分析. 歴史的政策分析.
- 麻薬の取得と流通システムの検討.
- 政府戦略と国際紛争の見直し.
主要な成果:
- ブラジルは国内で多くのARVを生産し,高価な医薬品を輸入しています.
- この政策の成功には,高い医薬品取得コストが課題となり,製薬会社との価格と特許の争いが引き起こされている.
結論:
- ブラジルのARVアクセス政策は,成功にもかかわらず,薬物コストからの継続的な脅威に直面しています.
- ブラジルの経験は,世界的に普遍的なHIV/AIDS治療を実施するための貴重な教訓を提供します.
キーワード:
保健医療と公衆衛生について関連する概念動画
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


